Literature DB >> 3018294

Coxsackievirus B3 infection alters plasma membrane of neonatal skin fibroblasts.

C W Lutton, C J Gauntt.   

Abstract

Replication of coxsackievirus B3 occurred for days in cultures of murine neonatal skin fibroblasts in the absence of cytopathology and resulted in alteration of the plasma membrane. Dual immunofluorescence studies showed that the lectin Ulex europaeus agglutinin I bound only to cells producing viral capsid antigens. Cultures of coxsackievirus B3-inoculated murine neonatal skin fibroblasts showed maximum binding of this lectin at 72 h postinoculation. These data show that in a nonlytic infection a picornavirus can alter the surface of an infected cell.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018294      PMCID: PMC253929     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue.

Authors:  R E Paque; C J Gauntt; T J Nealon; M D Trousdale
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

Review 2.  Viral myocarditis.

Authors:  D Lewes
Journal:  Practitioner       Date:  1976-03

3.  Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model.

Authors:  M D Trousdale; R E Paque; T Nealon; C J Gauntt
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

Review 4.  Viral Infections and diseases of the heart.

Authors:  A B Lansdown
Journal:  Prog Med Virol       Date:  1978

Review 5.  The lectins: carbohydrate-binding proteins of plants and animals.

Authors:  I J Goldstein; C E Hayes
Journal:  Adv Carbohydr Chem Biochem       Date:  1978       Impact factor: 12.200

6.  Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy.

Authors:  I W McLean; P K Nakane
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

7.  Purification and characterization of an anti-H(O) phytohemagglutinin of Ulex europeus.

Authors:  I Matsumoto; T Osawa
Journal:  Biochim Biophys Acta       Date:  1969-11-11

8.  Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.

Authors:  C Y Wong; J J Woodruff; J F Woodruff
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

9.  Cellular immune responses in mice challenged with an amyocarditic variant of Coxsackievirus B3.

Authors:  C W Lutton; R J Gudvangen; T J Nealon; R E Paque; C J Gauntt
Journal:  J Med Virol       Date:  1985-12       Impact factor: 2.327

10.  Fractionation and immunologic assessment of KCl-extracted cardiac antigens in coxsackievirus B3 virus-induced myocarditis.

Authors:  R E Paque; D C Straus; T J Nealon; C J Gauntt
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

View more
  6 in total

1.  In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis.

Authors:  E K Godeny; C J Gauntt
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

Review 2.  Role of cytotoxic T cells in experimental myocarditis.

Authors:  N Van Houten; S A Huber
Journal:  Springer Semin Immunopathol       Date:  1989

Review 3.  Anti-viral and anti-myocyte antibodies in experimental myocarditis.

Authors:  M Herzum; B Maisch
Journal:  Springer Semin Immunopathol       Date:  1989

Review 4.  Role of natural killer cells in experimental murine myocarditis.

Authors:  C J Gauntt; E K Godeny; C W Lutton; G Fernandes
Journal:  Springer Semin Immunopathol       Date:  1989

5.  Serological probes for some foot-and-mouth disease virus nonstructural proteins.

Authors:  M Tesar; H G Berger; O Marquardt
Journal:  Virus Genes       Date:  1989-09       Impact factor: 2.332

Review 6.  Clinical and experimental aspects of viral myocarditis.

Authors:  K Leslie; R Blay; C Haisch; A Lodge; A Weller; S Huber
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.